Skip to content

Clinical trials

Terminated Schizophrenia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Terminated Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20072
20082
20093
20112
20153
20161
20181
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Denovo Biopharma LLC2
H. Lundbeck A/S2
Hannover Medical School2
M. Schaefer, MD2
Boehringer Ingelheim1
Bristol-Myers Squibb1
Central Institute of Mental Health, Mannheim1
Janssen Pharmaceutica N.V., Belgium1
Janssen-Cilag G.m.b.H1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia19
Anxiety Disorders2
Cognitive Dysfunction2
Psychotic Disorders2
Alzheimer Disease1
Arrhythmias, Cardiac1
Asthma1
Body Weight Changes1
Cognition Disorders1
Coronary Disease1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.